CD8A and COVID-19: Metabolic changes in CD8+ T cells are currently identified in COVID-19 patients showing a decreased ability to upregulate cellular metabolism by decreased activation of mTOR signaling early after activation, coupled with additional defects in metabolic reprogramming to glycolysis (93).